Post-IPO Equity Biotechnology Companies

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

TAO Synergies is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.

Quoin Pharmaceuticals is into developing products which address major unmet medical needs.

Aptorum Group is a pharmaceutical company dedicated to the development of therapeutic assets to treat diseases with unmet medical needs.

Xenetic Biosciences is a biopharmaceutical company that provides drugs, cancer therapies, and vaccines.

Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma.

We want to transform healthcare by developing novel vaccines that are lifesaving and improving quality of life around the world.

Cypherpunk is a biopharmaceutical company developing antibody therapies for cancer while executing a digital-asset treasury strategy.

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.

RenalytixAI is a developer of artificial intelligence-enabled clinical diagnostic solutions for kidney health.

PepGen is empowering nucleic acid therapeutics to go the distance.

Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.

Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

TNF Pharmaceuticals is researching groundbreaking treatments to address serious and debilitating autoimmune and inflammatory illnesses.